John Libbey Eurotext

Médecine thérapeutique / Endocrinologie

MENU

Cardiovascular risks and benefits of hormone therapy Volume 6, issue 1, Janvier-Février 2004

Figures

See all figures

Author
Director of the Institut Palacios of Woman’s Health. Calle Antonio Acuña, 9, 28009, Madrid (Spain)

Auteur(s) : Dr. Santiago Palacios Director of the Institut Palacios of Woman’s Health.  Calle Antonio Acuña, 9, 28009, Madrid (Spain) The majority of the observational studies have coincided in that HT (Hormone Therapy) is associated to a coronary risk reduction of about 30 to 50% [1-2]. These results have biological plausibility due to the fact that HT is associated to a series of benefits on the cardiovascular risk factors (improved lipid profile, decreased insulin resistance, fibrinogen [...]